445 related articles for article (PubMed ID: 12493176)
1. Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns.
Sader HS; Jones RN; Silva JB;
Diagn Microbiol Infect Dis; 2002 Nov; 44(3):281-8. PubMed ID: 12493176
[TBL] [Abstract][Full Text] [Related]
2. Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study Group.
Gales AC; Jones RN; Pfaller MA; Gordon KA; Sader HS
Int J Infect Dis; 2000; 4(2):75-84. PubMed ID: 10737843
[TBL] [Abstract][Full Text] [Related]
3. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
[TBL] [Abstract][Full Text] [Related]
4. Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers.
Sader HS; Jones RN; Andrade-Baiocchi S; Biedenbach DJ;
Diagn Microbiol Infect Dis; 2002 Nov; 44(3):273-80. PubMed ID: 12493175
[TBL] [Abstract][Full Text] [Related]
5. Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from latin american patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998).
Lewis MT; Gales AC; Sader HS; Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 2000 May; 37(1):63-74. PubMed ID: 10794943
[TBL] [Abstract][Full Text] [Related]
6. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.
Fedler KA; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):427-36. PubMed ID: 16938419
[TBL] [Abstract][Full Text] [Related]
7. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
[TBL] [Abstract][Full Text] [Related]
8. Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).
Kirby JT; Mutnick AH; Jones RN; Biedenbach DJ; Pfaller MA
Diagn Microbiol Infect Dis; 2002 Aug; 43(4):303-9. PubMed ID: 12151191
[TBL] [Abstract][Full Text] [Related]
9. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000).
Gales AC; Sader H HS; Jones RN
Diagn Microbiol Infect Dis; 2002 Nov; 44(3):301-11. PubMed ID: 12493178
[TBL] [Abstract][Full Text] [Related]
10. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America).
Doern GV; Jones RN; Pfaller MA; Kugler KC; Beach ML
Diagn Microbiol Infect Dis; 1999 May; 34(1):65-72. PubMed ID: 10342110
[TBL] [Abstract][Full Text] [Related]
11. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000).
Rennie RP; Jones RN; Mutnick AH;
Diagn Microbiol Infect Dis; 2003 Apr; 45(4):287-93. PubMed ID: 12730001
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group.
Sader HS; Jones RN; Gales AC; Winokur P; Kugler KC; Pfaller MA; Doern GV
Diagn Microbiol Infect Dis; 1998 Dec; 32(4):289-301. PubMed ID: 9934546
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).
Gales AC; Castanheira M; Jones RN; Sader HS
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):354-60. PubMed ID: 22656912
[TBL] [Abstract][Full Text] [Related]
15. Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000).
Gales AC; Sader HS; Jones RN;
Diagn Microbiol Infect Dis; 2002 Nov; 44(3):289-99. PubMed ID: 12493177
[TBL] [Abstract][Full Text] [Related]
16. Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group.
Jones ME; Schmitz FJ; Fluit AC; Acar J; Gupta R; Verhoef J
Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):403-8. PubMed ID: 10442417
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997.
Jones RN; Kugler KC; Pfaller MA; Winokur PL
Diagn Microbiol Infect Dis; 1999 Sep; 35(1):55-63. PubMed ID: 10529882
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
19. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
Sader HS; Farrell DJ; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
